News and Analysis

Scribe Therapeutics procures $20m Series A

Alameda, California-based Scribe Therapeutics Inc., a provider of a platform for CRISPR-based genetic medicine, has secured $20 million in Series A funding.

-

Alameda, California-based Scribe Therapeutics Inc., a provider of a platform for CRISPR-based genetic medicine, has secured $20 million in Series A funding. The investors included Andreessen Horowitz.

Source: Press Release